Monday, July 22, 2013

Adamat | Methyl Dopa - severe, moderate hypertension



Adamat 250 mg
Methyl Dopa 250 mg

Company Name
El Nasr

Pharmaceutical form
Capsule

Package
Pack of 30 Capsules in 5 strips , each of 6 Capsules . Pack of 1002 capsules in strips , each of 6 capsules [Hospital pack].

Indications
Used in severe, moderate hypertension in combination with diuretics and beta blocker

Warning & Precautions
- Methyldopa should be used with caution in patients with a history of previous liver disease or dysfunction (see WARNINGS ). - Some patients taking methyldopa experience clinical edema or weight gain which may be controlled by use of a diuretic





















Product Type
Human

Dosage
The usual initial dose by mouth is the equivalent to 250mg. of anhydrous methyl dopa 2 - 3 times daily for 2 days ; this is then adjusted by small increments or decrements

Adverse Reactions
- Cardiovascular : Aggravation of angina pectoris, congestive heart failure . - Digestive : Pancreatis, Colitis, vomiting, diarrhea. Endocrine : Hyperprolactinemia

Contra Indications
- with hypersensitivity to any component of these products - on therapy with monoamine oxidase (MAO) inhibitors

Drug Interactions
- When methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur. Patients should be followed carefully to detect side reactions or unusual manifestations of drug idiosyncrasy






5 EgyDrug Index: Adamat | Methyl Dopa - severe, moderate hypertension Adamat 250 mg Methyl Dopa 250 mg Company Name El Nasr Pharmaceutical form Capsule Package Pack of 30 Capsules in 5 strips , each...

No comments:

Post a Comment